ALR : Summary for Alere Inc. Common Stock - Yahoo Finance

U.S. Markets close in 43 mins.

Alere Inc. (ALR)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
40.15-0.22 (-0.54%)
As of 3:17PM EST. Market open.
People also watch
BIOHAEHOLXPODDABAX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close40.37
Open40.29
Bid0.00 x
Ask0.00 x
Day's Range39.94 - 40.37
52 Week Range31.47 - 53.96
Volume293,934
Avg. Volume597,672
Market Cap3.49B
Beta-0.67
PE Ratio (TTM)-57.28
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga29 days ago

    Wall Street's M&A Chatter From January 25

    The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday January 25, 2017. EU clears Abbott Acquisition of Alere Subject to Divestments The Approval : Alere Inc (NYSE: ...

  • PR Newswirelast month

    European Commission Clears Abbott Acquisition of Alere

    WALTHAM, Mass., Jan. 25, 2017 /PRNewswire/ -- Alere Inc. (ALR), a global leader in rapid diagnostics, announced that the European Commission has granted clearance for Abbott Laboratories (ABT) to acquire Alere Inc. "This regulatory clearance marks a significant milestone toward the completion of our transaction with Abbott and we remain highly confident that the merger will close according to the terms of the agreement," said Namal Nawana, CEO and President of Alere. As previously announced on February 1, 2016, Alere has entered into a definitive agreement under which Abbott will acquire Alere for $56 per common share in cash.

  • Reuterslast month

    EU clears Abbott acquisition of Alere subject to divestments

    European Union antitrust regulators cleared Abbott Laboratories' proposed $5.8 billion acquisition of diagnostic test maker Alere on Wednesday, subject to the divestment of some of Alere's operations. The European Commission, which is in charge of competition policy in the European Union, said there were overlaps in analysers used in testing of blood gases and cardiac markers.